Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1924 publications
Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight US$ 2,400.00

... Angiogenesis Inhibitors Metronomic Therapy - A Recent Advancement in Anti-Angiogenesis Therapy Global Cancer Angiogenesis Inhibitors Clinical Pipeline by Company, Indication & Phase Global Cancer Angiogenesis Inhibitors Clinical Pipeline: 146 Drugs Marketed Cancer Angiogenesis Inhibitors Drugs: 11 Drugs ...

Aug, 2016 660 pages
Thyroid Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Thyroid Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Testicular cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Testicular cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Oropharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Oropharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Oral Mucositis - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Oral Mucositis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Neuroendocrine Carcinoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Nasopharyngeal Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Nasopharyngeal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Myelodysplastic Syndrome- Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Myelodysplastic Syndrome - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Lip and Oral Cavity Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Lip and Oral Cavity Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Lip and Oral Cavity Cancer ...

Sep, 2016 100 pages
Larynx Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Larynx Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Human Papillomavirus (HPV) market. Identifying patient populations in the global “Human Papillomavirus (HPV)market to improve product design, pricing, and launch plans. Organize sales and marketing ...

Sep, 2016 100 pages
Gastrointestinal Stromal Tumors (GIST)- Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Gastrointestinal Stromal Tumors (GIST) market. Identifying patient populations in the global “Gastrointestinal Stromal Tumors (GIST)market to improve product design, pricing, and launch plans. Organize sales and marketing ...

Sep, 2016 100 pages
Gastric Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Gastric Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Gallbladder Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Gallbladder Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Esophageal Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Esophageal Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Endometrial Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Chronic Myelocytic Leukemia (CML) - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Chronic Myelocytic Leukemia (CML) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Myelocytic Leukemia (CML ...

Sep, 2016 100 pages
Chemotherapy Induced Neutropenia  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Chemotherapy Induced Neutropenia market. Identifying patient populations in the global “Chemotherapy Induced Neutropeniamarket to improve product design, pricing, and launch plans. Organize sales and marketing ...

Sep, 2016 100 pages
Chemotherapy Induced Nausea and Vomiting  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Chemotherapy Induced Nausea and Vomiting forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chemotherapy Induced Nausea and Vomiting ...

Sep, 2016 100 pages
Cervical Cancer  - Market Insights, Epidemiology and Market Forecast-2023 US$ 4,950.00

... Cervical Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ...

Sep, 2016 100 pages
Global Small Molecule Targeted Cancer Therapy Market Report 2016 US$ 2,850.00

2016 Global Small Molecule Targeted Cancer Therapy Report is a professional and in-depth research report on the world's major regional market conditions of the Small Molecule Targeted Cancer Therapy industry, focusing ... : 1.) basic information; 2.) the Asia Small Molecule Targeted Cancer Therapy industry; 3.) the North American Small Molecule Targeted Cancer Therapy industry; 4.) the European Small Molecule Targeted Cancer Therapy industry; 5.) market entry and ...

Aug, 2016 151 pages
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 US$ 4,000.00

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016' provides an overview of Colorectal Cancer Diagnostic Tests ...

Aug, 2016 288 pages
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 US$ 4,000.00

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016' provides an overview of Cervical Cancer Diagnostic Tests ...

Aug, 2016 93 pages
T-Cell Immunotherapy for Cancer - Pipeline Analysis US$ 1,500.00

... is cancer immunotherapy, particularly T-cell immunotherapy. T-cell immunotherapy has shown great promise in the treatment of patients with late-stage cancer. According to RNCOS’ new research report “T-Cell Immunotherapy for Cancer - Pipeline Analysis”, T-cell immunotherapy ...

Aug, 2016 75 pages
US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones,... US$ 9,800.00

... US cancer diagnostics market during the nextfive years. The report examines trends in the US market; reviews current and emerging assays; analyzes potential applications of new diagnostic ... tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...

Aug, 2016 620 pages
Global Cancer Tyrosine Kinase Inhibitors Market & Clinical Pipeline Outlook 2020 US$ 3,000.00

... Cancer Tyrosine Kinase Inhibitors Signaling Pathway of Receptor Tyrosine Kinase Advantage of Tyrosine Kinase Inhibitors for Treatment of Cancer Applications of Tyrosine Kinase Inhibitor in Cancer Therapy Global Tyrosine Kinase Inhibitors Market Overview Global Cancer Tyrosine Kinase Inhibitors ...

Aug, 2016 1100 pages
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016 US$ 3,500.00

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016 SUMMARY Global Markets Direct’s, ‘Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L ...

Jun, 2016 79 pages
Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software),... US$ 5,650.00

... liquid biopsy market on the basis of cancer type, circulating biomarkers, end users, products & services, and regions. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancers (melanoma, bladder cancer, and ovarian cancer). Based on circulating biomarkers, the liquid biopsy market ...

Jul, 2016 161 pages
Cancer Diagnostics Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

... .com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market ...

Jul, 2016 80 pages
Global Cancer Immunotoxins Market & Clinical Pipeline Insight 2020 US$ 2,400.00

... Immunotoxins to Multiple Cancer Therapies Global Cancer Immunotoxins Market Future Prospects Global Cancer Immunotoxins Clinical Pipeline by Company, Indication & Phase Global Cancer Immunotoxins Clinical Pipeline: 52 Cancer Immunotoxins Majority Cancer Immunotoxins ...

Jul, 2016 240 pages
Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021) (By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound,... US$ 2,400.00

... resulted in the growth of global cancer diagnostics market Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve ... report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been ...

Jul, 2016 132 pages
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics US$ 4,995.00

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics Summary Urological cancers ...

Jun, 2016 143 pages
Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis US$ 9,495.00

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the ... and CAR-T therapies. Revenue by indications for major IO products in 2019 and 2024. Key topics covered include strategic competitor assessment, market characterization ...

May, 2016 423 pages
Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis US$ 1,850.00

... the other top contributors to the global breast cancer screening population. iGATE RESEARCH report titled “Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 ... Breast Cancer Screening Population, Market and Forecast 2. Breast Cancer Mammography Screening Population and Forecast 3. Breast Cancer MRI and Ultrasound Screening Population and Forecast 4. Breast Cancer Mammography Screening Market and Forecast 5. Breast Cancer MRI Screening Market and Forec

Jul, 2016 510 pages
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies US$ 6,995.00

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies Summary Hematological malignancies are a class of cancer ...

Jun, 2016 73 pages
Cancer Diagnostics: US, Europe, Japan-Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers US$ 34,750.00

... in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; ... Japan, Spain, UK, USA Worldwide Market Overview Five-year test volume and sales projections by country. Comprehensive market segmentation analysis, including review of the market ...

Jun, 2016 1200 pages
Spain Cancer Diagnostics Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers US$ 6,800.00

... analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics markets; reviews ... . Market Segmentation Analysis Sales and market shares of major suppliers, by individual cancer diagnostic test. Five-year test volume and sales forecasts for major cancer diagnostic tests by market ...

Jun, 2016 565 pages
Cancer Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers US$ 3,850.00

This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.

Jun, 2016 119 pages
Cancer Diagnostic Tests, and Strategic Profile of Leading Reagent and Instrument Suppliers US$ 3,850.00

... , as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth ...

Jun, 2016 286 pages
Cancer Diagnostics: US, Europe, Japan--Country Segment Volume and Sales Forecasts, Laboratory Universe US$ 2,850.00

... cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer ...

Jun, 2016 11 pages
Cancer Diagnostic Test Volume and Sales Forecasts by Country US$ 2,450.00

... cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and ...

Jun, 2016 11 pages
Cancer Diagnostics: Major Suppliers Strategic Assessments US$ 2,500.00

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution ...

Jun, 2016 80 pages
Cancer Diagnostics: Profiles of Leading Suppliers US$ 2,500.00

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages

Jun, 2016 80 pages
Cancer Diagnostics Market: Strategic Assessments of Current and Emerging Competitors US$ 2,500.00

... .com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market ...

Jul, 2016 80 pages
Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers US$ 3,850.00

... technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...

Jun, 2016 185 pages
Cancer Diagnostics Market: Sales Forecasts by Country, Strategic Profiles of Leading Suppliers, Emerging Tests, Innovative Technologies, Instrumentation Review US$ 7,500.00

... global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer testing ... volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S. Marketing and technological assessment, as well as medical rationale and diagnostic prospects for ...

Jul, 2016 510 pages
Next Generation Cancer Diagnostics Market Size & Forecast By Technology (DNA & Protein Microarrays, Lab-on-a-chip, RT-PCR & Multiplexing, & NGS Sequencing), By Function (Risk Analysis,... US$ 4,700.00

Global next generation cancer diagnostics market is anticipated to reach USD 20.25 billion by 2022 growing at an estimated CAGR of 32.0% from ... rendering driver in this region. Key players contributing significantly to the next generation cancer diagnostics market are Novartis AG, Cepheid, Roche Holdings AG, Perkin Elmer Inc., Sysmex ...

Feb, 2016 75 pages
Genomics In Cancer Care Market Analysis By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Research), By... US$ 4,700.00

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption ... cancer are responsible for the potential growth of genomics in cancer care. Further key findings from the study suggest: Instrument segment dominated the overall market ...

Feb, 2016 80 pages
Ovarian Cancer-Pipeline Insights, 2016 US$ 2,250.00

... pipeline assets across the Ovarian Cancer. The Report gives insights on 225+ products. It also includes around 185+ companies which are active in this field. DelveInsight’s, Ovarian Cancer -Pipeline Insights, 2016 Report covers the pipeline ...

Jul, 2016 260 pages
1 2 3 4 5 >
Skip to top